SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-025907
Filing Date
2018-04-23
Accepted
2018-04-23 18:28:34
Documents
2
Period of Report
2018-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1547
2 POA DOCUMENT poa.txt EX-24.3_784798 3921
  Complete submission text file 0001209191-18-025907.txt   6837
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address
Reasons Bryan M. (Reporting) CIK: 0001553489 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 18769751

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations